
Lenvat 4 Capsule
Marketer
Natco Pharma Ltd
Salt Composition
Lenvatinib (4mg)
Overview Lenvat 4 Capsule
E777 capsules, a tyrosine kinase inhibitor administered orally, are indicated for thyroid cancer management. While consumption with or without food is acceptable, consistent daily timing optimizes therapeutic efficacy. Dosage and frequency are determined by your physician based on individual needs and may be adjusted. Adhere strictly to your prescribed regimen; deviations or overdosage can lead to severe adverse reactions. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Frequently reported side effects include lethargy, arthralgia, myalgia, nausea, hypotension, asthenia, diarrhea, and emesis. Severe headache, cognitive impairment, visual disturbances, and dysphasia may also occur, potentially signaling hypertension requiring blood pressure monitoring. Severe diarrhea necessitates medical consultation or increased fluid intake. Report intense abdominal pain, melena, or hematochezia, as these may indicate a bleeding disorder. Liver, kidney, and thyroid-stimulating hormone levels will likely be monitored via blood tests. Prior to commencing treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all concurrent medications, including antibiotics, as drug interactions are possible. This medication is contraindicated during gestation and lactation; reliable contraception is essential for both partners throughout therapy.
Uses of Lenvat 4 Capsule
Malignancy of the thyroid gland
Major Benefits of Lenvat 4 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lenvat 4 Capsules. These capsules can be taken with or without food, although consistent timing is recommended.
Common Side effects of Lenvat 4 Capsule:
- Vomiting
- Bleeding
- Cough
- Decreased appetite
- Itching
- Joint pain
- Mouth sore
- Muscle pain
- Nausea
- Peripheral edema
- Rash
- Stomach pain
- Tiredness
- Weight loss
- Diarrhea
- Fatigue
- Hypotension (low blood pressure)
How to use Lenvat 4 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lenvat 4 Capsules. These capsules can be ingested with or without food, however, consistent daily timing is recommended.
How Lenvat 4 Capsule works:
Lenvat 4 Capsules contain a tyrosine kinase inhibitor that restricts blood flow to cancerous cells, thereby inhibiting their growth and proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lenvat 4 Capsule lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Lenvat 4 Capsules during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Lenvat 4 Capsules while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Lenvat 4 Capsule on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when taking Lenvat 4 Capsules. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Lenvat 4 Capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Lenvat 4 Capsule :
Should you forget a Lenvat 4 Capsule dose, take it promptly. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Lenvat 4 Capsule
| Label | Value |
|---|---|
| Chemical Category | Quinoline-Based Carboxamides |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
